Top news of the week: 02.06.2020.
#CoronaVirus #biotechnology #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals #CoronaOutbreak #BIODigital #therapeutics
Companies And Industries
Book traversal links for The top 15 highest-paid biopharma CEOs of 2019
While the list of the best-paid biopharma CEOs of 2019 includes some of the world's largest drugmakers, you'll also find smaller companies among them. And the CEO at No. 1 could be a ...
The Dish’s Weekly Biotechnology News Wrap Up – May 29, 2020
This week's headlines include: Coronavirus discoveries can come along faster with adaptive clinical trials, South Africa BCG booster trials seek low-cost weapon against COVID-19, Will ...
Biopharma Update on the Novel Coronavirus: May 27
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/4FxSO5C79i
OpenBiopharma Update on the Novel Coronavirus: May 27
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 27, 2020.
Biopharma Update on the Novel Coronavirus: June 1
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/Hl7tNbhrMR
OpenBiopharma Update on the Novel Coronavirus: June 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 1, 2020.
Moderna executives have cashed out $89M in shares this year. Some no longer hold $MRNA stock, @damiangarde writes. https://t.co/y7wbfJzTLb
OpenModerna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes
With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action https://t.co/eXzQSkG4Sw https://t.co/J05VekOjwC
OpenBiotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Legend Biotech is living up to its name as it sets terms for a massive $350 million IPO, while early-stage cancer biotech Repare Therapeutics and blood-disease-focused Forma Therapeutics ...
RT @IAmBiotech: Discover @SutroBio, a clinical stage company working to develop the next generation of #therapeutics for diseases like #cancer and #autoimmune disorders. Learn more in our latest #BeyondImagination feature at @BIOConvention’s #BIODigital. https://t.co/Sgr2Exmbsf https://t.co/jUj24t408q
OpenThe Next Generation of Cancer Therapeutics
Our Biotechnology: Beyond Imagination series highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature is Sutro ...
.@Reuters: Novavax launches its first #coronavirus #vaccine test on humans https://t.co/aYOxEOkuCY
OpenNovavax launches its first coronavirus vaccine test on humans
U.S. biotech company Novavax Inc has joined the race to test coronavirus vaccine candidates on humans and said it was targeting production of over a billion doses of its vaccine candidate ...